
Cytovance in Agreement with Akshaya
The Journal Record website reported that Cytovance Biologics has entered into a collaboration agreement with Akshaya Bio Inc. to provide rapid access to clinical materials using Akshaya’s proprietary Chimigen Platform Technology for vaccine development for COVID-19 and hepatitis B vaccine. Oklahoma City-based Cytovance Biologics is a contract development
Comments Off on Cytovance in Agreement with Akshaya • Read this story »